Key opinions on SPIRIVA® Respimat® in asthma
We present a series of video interviews with leading experts in asthma and respiratory medicine, as well as family medicine practitioners.
Professor Halpin describes the role of acetylcholine in the pathophysiology of asthma and considers the efficacy and safety of SPIRIVA® (tiotropium) Respimat® as an add-on therapy in the treatment of patients with symptomatic asthma.
Professor Bateman looks at some common misconceptions around asthma and reveals the societal burden of asthma. The video also features patients discussing the impact asthma symptoms have on their daily lives at school, at work and at home.
Dr Fromer is an asthmatic and a family medical practitioner in the US. Here he talks about the causes of impairment, as well as the options available to doctors when treating adult patients with asthma including long-acting bronchodilators.
UK based General Practitioner Dr Gruffydd-Jones describes his experience of managing a highly atopic 48 years old patient with a history of rhinitis and eczema treated with SPIRIVA® Respimat®.
Dr Menzies-Gow explains the questioning techniques used in his clinics and the value of validated questionnaires, particularly the Asthma Control Test (ACT) and Juniper Asthma Control Questionnaire (ACQ), to assess symptom control.
Dr Gruffydd-Jones explains the role of primary care professionals in regularly monitoring asthma patients and stresses the need for good patient/doctor dialogue to ensure asthma management plans remain up-to-date and optimised.
Dr Rodriguez highlights the value of shared decision-making with asthma patients and empowering patients to self-manage their asthma symptoms. He stresses the importance of nursing staff in the delivery of improved multidisciplinary care.